Atomo Diagnostics (ASX:AT1) Cash-to-Debt : 14.55 (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Atomo Diagnostics Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Atomo Diagnostics's cash to debt ratio for the quarter that ended in Dec. 2024 was 14.55.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Atomo Diagnostics could pay off its debt using the cash in hand for the quarter that ended in Dec. 2024.

The historical rank and industry rank for Atomo Diagnostics's Cash-to-Debt or its related term are showing as below:

ASX:AT1' s Cash-to-Debt Range Over the Past 10 Years
Min: 14.55 Med: 38.02 Max: 484
Current: 14.55

During the past 5 years, Atomo Diagnostics's highest Cash to Debt Ratio was 484.00. The lowest was 14.55. And the median was 38.02.

ASX:AT1's Cash-to-Debt is ranked better than
76.81% of 858 companies
in the Medical Devices & Instruments industry
Industry Median: 1.73 vs ASX:AT1: 14.55

Atomo Diagnostics Cash-to-Debt Historical Data

The historical data trend for Atomo Diagnostics's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Atomo Diagnostics Cash-to-Debt Chart

Atomo Diagnostics Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

Jun24

Cash-to-Debt

484.00

263.93

38.02

25.37

25.97

Atomo Diagnostics Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Cash-to-Debt	Get a 7-Day Free Trial						37.36	25.37	38.07	25.97	14.55

Competitive Comparison of Atomo Diagnostics's Cash-to-Debt

For the Medical Devices subindustry, Atomo Diagnostics's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Atomo Diagnostics's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Atomo Diagnostics's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Atomo Diagnostics's Cash-to-Debt falls into.

Save Embed

;

Save Embed

;

Atomo Diagnostics Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Atomo Diagnostics's Cash to Debt Ratio for the fiscal year that ended in Jun. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	3.688	/	(0.085	+	0.057)
	=	25.97

Atomo Diagnostics's Cash to Debt Ratio for the quarter that ended in Dec. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	2.896	/	(0.174	+	0.025)
	=	14.55

Atomo Diagnostics (ASX:AT1) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Atomo Diagnostics Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Atomo Diagnostics's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Atomo Diagnostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Atomo Diagnostics Ltd (ASX:AT1) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

3 - 5 George Street, Level 1, Leichhardt, Syndey, NSW, AUS, 2040

Website

https://www.atomodiagnostics.com

Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The company is engaged in the development and sale of medical devices. The company develops point-of-care devices for rapid diagnostic testing. The company offers AtomoRapid RDT Platform with devices including Galileo, Pascal, Curie, and Elion. The firm operates in a single segment, medical device research and development.

Atomo Diagnostics Headlines

No Headlines